Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033929142> ?p ?o ?g. }
- W2033929142 abstract "The use of medicines in children is an area of increasing after this syndrome was noted, pharmacokinetic studiesinterest [1]. Many medicines are being used outside the showed that newborn infants had impaired metabolismterms of their product licence [2] thereby increasing of chloramphenicol and that a reduction of the dosagethe risk of drug toxicity. Clinicians need to ensure not from 100 mgkg−1daily to 50 mg kg−1daily preventedonly that toxicity is kept to a minimum but also that the development of this syndrome [12].children arenot denied theuse ofappropriate medicines.This can only be achieved by the scientific study of drugtoxicity in children and is ideally carried out byprospective studies of drug surveillance. This involvesspecifically monitoring for drug toxicity, either in Toxicity in youngchildrenrelation to particular drugs [3,4] or selected patientgroups [5,6].Drug use in children may be accompanied Althoughtheseinitialstudies described clinicalproblemsby problems not seen in adults, or cause adverse drug in newborn infants, and the preterm infant in particular,reactions that are more frequent than in adults. An problems with other drugs have highlighted theexampleofthisismetoclopramide whichcausesdystonia enhanced toxicity of some medicines in children.in teenagers and Parkinsonism in the elderly [7]. Hepatotoxicity in association with the anticonvulsantsodium valproate was initially reported in 1979 [13].Subsequently more than 100 patients died, the majorityof whom were children. A retrospective review [14] of37 patients who died in the USA, showed that thoseAntibiotictoxicity inneonates patients at greatest risk fell into one of three categories:(i) age under 3 years; (ii) receiving other anticonvuls-Infectionshavealwaysbeena majorprobleminneonates ants as well as valproate; (iii) developmental delay.with significant mortality and morbidity. The introduc- Subsequent changes in prescribing habits resulted in ation of antibiotic therapy resulted in major clinical dramatic reduction in the number of deaths due toadvances [8]. However, antibiotic therapy also pro- sodium valproate [15]. The mechanism of valproateduced particular clinical problems. Silverman et al. hepatotoxicity is not fully understood but is thought toreported considerably higher mortality in neonates relate to abnormal metabolism [16]. Other anticonvul-receiving a combination of penicillin and sulphisoxazole sants result in enzyme induction and, therefore, enhancethan those receiving oxytetracycline [9]. There was a certain metabolic pathways resulting in the formationsignificantly higher incidence of kernicterus, both clini- of toxic intermediate metabolites. These pathways maycally(opisthotonos,spasticity,seizures, oculogyricmove- be more prominent in children under the age of 3 yearsments) and pathologically (yellow staining of the brain) and it is important to realise that drug metabolism inin the children who died following penicillin and the children differs from that of adults.sulphonamide. Subsequently, others have shown that The other drug causing hepatotoxicity specifically insulphonamides are highly protein bound and displace children was aspirin. The use of salicylates in childrenbilirubin from albumin [10]. As the preterm infant is with a mild viral infection resulted in a greater risk ofusually jaundiced, the sulphonamide displaced bilirubin developing Reye’s syndrome—a life threatening illnessfrom albumin and this is thought to increase the associated with drowsiness, coma, hypoglycaemia, seiz-incidence of kernicterus. ures and liver failure. Epidemiological work confirmedNewborninfants receivingchloramphenicoldeveloped the association between salicylate ingestion and theabdominaldistension,vomiting, cyanosis,cardiovascular development of Reye’s syndrome [17], although thecollapse, irregular respiration and subsequent death possible association had been postulated 15 years[11]. This was termed the grey baby syndrome. Shortly previously [18]. Starko et al. [17] studied children" @default.
- W2033929142 created "2016-06-24" @default.
- W2033929142 creator A5014738849 @default.
- W2033929142 creator A5015965214 @default.
- W2033929142 creator A5077489209 @default.
- W2033929142 date "1996-10-01" @default.
- W2033929142 modified "2023-09-29" @default.
- W2033929142 title "Drug toxicity and surveillance in children" @default.
- W2033929142 cites W159611851 @default.
- W2033929142 cites W1603143847 @default.
- W2033929142 cites W1969130136 @default.
- W2033929142 cites W1970219260 @default.
- W2033929142 cites W1970437622 @default.
- W2033929142 cites W1977307548 @default.
- W2033929142 cites W1997000081 @default.
- W2033929142 cites W1999391512 @default.
- W2033929142 cites W2000742403 @default.
- W2033929142 cites W2003203153 @default.
- W2033929142 cites W2007145385 @default.
- W2033929142 cites W2008792459 @default.
- W2033929142 cites W2019170968 @default.
- W2033929142 cites W2029943098 @default.
- W2033929142 cites W2039739672 @default.
- W2033929142 cites W2043041894 @default.
- W2033929142 cites W2044518710 @default.
- W2033929142 cites W2047699820 @default.
- W2033929142 cites W2049125887 @default.
- W2033929142 cites W2050329464 @default.
- W2033929142 cites W2059293500 @default.
- W2033929142 cites W2067088801 @default.
- W2033929142 cites W2081536066 @default.
- W2033929142 cites W2093442348 @default.
- W2033929142 cites W2094161736 @default.
- W2033929142 cites W2094362295 @default.
- W2033929142 cites W2099161740 @default.
- W2033929142 cites W2121851624 @default.
- W2033929142 cites W2131035163 @default.
- W2033929142 cites W2143504904 @default.
- W2033929142 cites W2153556932 @default.
- W2033929142 cites W2161898999 @default.
- W2033929142 cites W2163954127 @default.
- W2033929142 cites W2320567313 @default.
- W2033929142 cites W2396763392 @default.
- W2033929142 cites W2409800341 @default.
- W2033929142 cites W2410196717 @default.
- W2033929142 cites W2414932423 @default.
- W2033929142 cites W2465842841 @default.
- W2033929142 cites W2486713628 @default.
- W2033929142 cites W2984518518 @default.
- W2033929142 cites W78539323 @default.
- W2033929142 cites W1868592532 @default.
- W2033929142 cites W2411340426 @default.
- W2033929142 doi "https://doi.org/10.1046/j.1365-2125.1996.04563.x" @default.
- W2033929142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2042692" @default.
- W2033929142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8904610" @default.
- W2033929142 hasPublicationYear "1996" @default.
- W2033929142 type Work @default.
- W2033929142 sameAs 2033929142 @default.
- W2033929142 citedByCount "24" @default.
- W2033929142 countsByYear W20339291422012 @default.
- W2033929142 countsByYear W20339291422013 @default.
- W2033929142 countsByYear W20339291422014 @default.
- W2033929142 countsByYear W20339291422015 @default.
- W2033929142 countsByYear W20339291422016 @default.
- W2033929142 countsByYear W20339291422017 @default.
- W2033929142 countsByYear W20339291422020 @default.
- W2033929142 countsByYear W20339291422023 @default.
- W2033929142 crossrefType "journal-article" @default.
- W2033929142 hasAuthorship W2033929142A5014738849 @default.
- W2033929142 hasAuthorship W2033929142A5015965214 @default.
- W2033929142 hasAuthorship W2033929142A5077489209 @default.
- W2033929142 hasBestOaLocation W20339291422 @default.
- W2033929142 hasConcept C126322002 @default.
- W2033929142 hasConcept C187212893 @default.
- W2033929142 hasConcept C197934379 @default.
- W2033929142 hasConcept C2780035454 @default.
- W2033929142 hasConcept C29730261 @default.
- W2033929142 hasConcept C2992092908 @default.
- W2033929142 hasConcept C71924100 @default.
- W2033929142 hasConcept C98274493 @default.
- W2033929142 hasConceptScore W2033929142C126322002 @default.
- W2033929142 hasConceptScore W2033929142C187212893 @default.
- W2033929142 hasConceptScore W2033929142C197934379 @default.
- W2033929142 hasConceptScore W2033929142C2780035454 @default.
- W2033929142 hasConceptScore W2033929142C29730261 @default.
- W2033929142 hasConceptScore W2033929142C2992092908 @default.
- W2033929142 hasConceptScore W2033929142C71924100 @default.
- W2033929142 hasConceptScore W2033929142C98274493 @default.
- W2033929142 hasLocation W20339291421 @default.
- W2033929142 hasLocation W20339291422 @default.
- W2033929142 hasLocation W20339291423 @default.
- W2033929142 hasLocation W20339291424 @default.
- W2033929142 hasOpenAccess W2033929142 @default.
- W2033929142 hasPrimaryLocation W20339291421 @default.
- W2033929142 hasRelatedWork W2023487034 @default.
- W2033929142 hasRelatedWork W2080948320 @default.
- W2033929142 hasRelatedWork W2141260063 @default.
- W2033929142 hasRelatedWork W2170381017 @default.
- W2033929142 hasRelatedWork W2397868246 @default.
- W2033929142 hasRelatedWork W2402651161 @default.